UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 Trial

Journal of clinical oncology, 2006-11, Vol.24 (31), p.4976-4982

2006

Volltextzugriff (PDF)

Progression-Free Survival Is a Surrogate for Survival in Advanced Colorectal Cancer

Journal of clinical oncology, 2007-11, Vol.25 (33), p.5218-5224

2007

Volltextzugriff (PDF)

Phase III Study Comparing a Semimonthly With a Monthly Regimen of Fluorouracil and Leucovorin As Adjuvant Treatment for Stage II and III Colon Cancer Patients: Final Results of GERCOR C96.1

Journal of clinical oncology, 2007-08, Vol.25 (24), p.3732-3738

2007

Volltextzugriff (PDF)

Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial

Journal of clinical oncology, 2003-08, Vol.21 (15), p.2896-2903

2003

Volltextzugriff (PDF)

Modulation of Fluorouracil by Leucovorin in Patients With Advanced Colorectal Cancer: An Updated Meta-Analysis

Journal of clinical oncology, 2004-09, Vol.22 (18), p.3766-3775

2004

Volltextzugriff (PDF)

Réparation cellulaire: casser la voie

Bulletin du cancer, 2011-03, Vol.98 (3), p.225-226

Piedbois, Pascal

2011

Volltextzugriff (PDF)

Meta-analyses based on abstracted data: a step in the right direction, but only a first step

Journal of clinical oncology, 2004-10, Vol.22 (19), p.3839-3841

2004

Volltextzugriff (PDF)

Therapie

Therapie, 2017-02, Vol.72 (1), p.39-49

2017

Volltextzugriff (PDF)

Critères d’évaluation des thérapeutiques dans les cancers de la prostate avancés

Bulletin du cancer, 2012-07, Vol.99 (1), p.S16-S20

2012

Volltextzugriff (PDF)

Critères d'évaluation des thérapeutiques dans Les cancers de la prostate avancés: Prise en charge des cancers de la prostate avancés

Bulletin du cancer, 2012, Vol.99

2012

Volltextzugriff (PDF)

Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis

The Lancet (British edition), 2000-07, Vol.356 (9227), p.373-378

2000

Volltextzugriff (PDF)

Randomised phase II trials in oncology

Bulletin du cancer, 2007-11, Vol.94 (11), p.953

Piedbois, Pascal

2007

Volltextzugriff (PDF)

Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer

Journal of clinical oncology, 1998, Vol.16 (1), p.301-308

1998

Volltextzugriff (PDF)

Should Dukes' B patients receive adjuvant therapy? A statistical perspective

Seminars in oncology, 2001-02, Vol.28 (1B), p.20-24, Article asonc0280020

2001

Volltextzugriff (PDF)

Toxicity of fluorouracil in patients with advanced colorectal cancer : Effect of administration schedule and prognostic factors

Journal of clinical oncology, 1998-11, Vol.16 (11), p.3537-3541

1998

Volltextzugriff (PDF)

Criteria and endpoints in advanced prostate cancer

Bulletin du cancer, 2012-07, Vol.99 Suppl 1, p.S16

2012

Volltextzugriff (PDF)

Efficacy of Oral Adjuvant Therapy After Resection of Colorectal Cancer: 5-Year Results From Three Randomized Trials

Journal of clinical oncology, 2004-02, Vol.22 (3), p.484-492

2004

Volltextzugriff (PDF)

Meta-analysis when only the median survival times are known: A comparison with individual patient data results

International journal of technology assessment in health care, 2005, Vol.21 (1), p.119-125

2005

Volltextzugriff (PDF)

Meta-analysis based on individual patient data: example of advanced colorectal cancer

Recherche en soins infirmiers, 2010-06 (101), p.25

2010

Volltextzugriff (PDF)

Méta-analyses sur données individuelles : exemple des cancers colorectaux métastatiques

Recherche en soins infirmiers, 2010-06, Vol.N° 101 (2), p.25-28

2010

Volltextzugriff (PDF)

5FU/LV with or without irinotecan in patients with resected stage II-III rectal cancer: Final analysis of R98 intergroup study

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3542-3542

2013

Volltextzugriff (PDF)

Fixed-dose rate gemcitabine in elderly patients with advanced pancreatic cancer: An observational study

Critical reviews in oncology/hematology, 2008-11, Vol.68 (2), p.178-182

2008

Volltextzugriff (PDF)

Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 randomized phase II study

Annals of oncology, 2007-01, Vol.18 (1), p.52-57

2007

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(50)
Life Sciences & Biomedicine
(48)
Science & Technology
(48)
Biological And Medical Sciences
(33)
Medical Sciences
(33)
Oncology
(29)
Female
(22)
Male
(21)
Middle Aged
(21)
Adult
(18)
Aged
(17)
Pharmacology. Drug Treatments
(17)
Tumors
(16)
Chemotherapy
(15)
Antineoplastic Agents
(14)
Treatment Outcome
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Fluorouracil - Administration & Dosage
(12)
Gastroenterology. Liver. Pancreas. Abdomen
(11)
Survival Rate
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 Trial

Progression-Free Survival Is a Surrogate for Survival in Advanced Colorectal Cancer

Phase III Study Comparing a Semimonthly With a Monthly Regimen of Fluorouracil and Leucovorin As Adjuvant Treatment for Stage II and III Colon Cancer Patients: Final Results of GERCOR C96.1

Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial

A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer

Modulation of Fluorouracil by Leucovorin in Patients With Advanced Colorectal Cancer: An Updated Meta-Analysis

Réparation cellulaire: casser la voie

Meta-analyses based on abstracted data: a step in the right direction, but only a first step

Therapie

Critères d’évaluation des thérapeutiques dans les cancers de la prostate avancés

Critères d'évaluation des thérapeutiques dans Les cancers de la prostate avancés: Prise en charge des cancers de la prostate avancés

Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis

Randomised phase II trials in oncology

Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer

Should Dukes' B patients receive adjuvant therapy? A statistical perspective

Toxicity of fluorouracil in patients with advanced colorectal cancer : Effect of administration schedule and prognostic factors

Criteria and endpoints in advanced prostate cancer

Efficacy of Oral Adjuvant Therapy After Resection of Colorectal Cancer: 5-Year Results From Three Randomized Trials

Meta-analysis when only the median survival times are known: A comparison with individual patient data results

Meta-analysis based on individual patient data: example of advanced colorectal cancer

Méta-analyses sur données individuelles : exemple des cancers colorectaux métastatiques

5FU/LV with or without irinotecan in patients with resected stage II-III rectal cancer: Final analysis of R98 intergroup study

Fixed-dose rate gemcitabine in elderly patients with advanced pancreatic cancer: An observational study

Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 randomized phase II study

Suchergebnisse filtern